These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7583181)

  • 21. Antireactive properties of "chondroprotective" drugs.
    Setnikar I
    Int J Tissue React; 1992; 14(5):253-61. PubMed ID: 1300311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Need for common internal controls when assessing the relative efficacy of pharmacologic agents using a meta-analytic approach: case study of cyclooxygenase 2-selective inhibitors for the treatment of osteoarthritis.
    Lee C; Hunsche E; Balshaw R; Kong SX; Schnitzer TJ
    Arthritis Rheum; 2005 Aug; 53(4):510-8. PubMed ID: 16082648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The present state of chondroprotective therapy in osteoarthrosis].
    Pelísková Z; Trnavský K; Krajícková-Trnavská J
    Acta Chir Orthop Traumatol Cech; 1989 Jun; 56(3):185-9. PubMed ID: 2526987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis.
    Morreale P; Manopulo R; Galati M; Boccanera L; Saponati G; Bocchi L
    J Rheumatol; 1996 Aug; 23(8):1385-91. PubMed ID: 8856618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis.
    Rabeneck L; Goldstein JL; Vu A; Mayne TJ; Rublee DA
    Am J Gastroenterol; 2005 May; 100(5):1043-50. PubMed ID: 15842577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
    Hochberg MC
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):4-14. PubMed ID: 12528069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rofecoxib: new preparation. A disappointing NSAID analgesic.
    Prescrire Int; 2000 Dec; 9(50):166-7, 169. PubMed ID: 11475491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of efficacy and tolerability of ketoprofen and piroxicam.
    Lang E; Steger W
    Br J Clin Pract; 1981; 35(7-8):267. PubMed ID: 7032566
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical features and medical management of osteoarthritis at the hand and wrist.
    Docken WP
    Hand Clin; 1987 Aug; 3(3):337-49. PubMed ID: 3654769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and conduct of clinical trials in osteoarthritis.
    Altman RD
    Scand J Rheumatol Suppl; 1990; 81():24-7. PubMed ID: 2137644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chondroprotection with chondroitin sulfate.
    Pipitone VR
    Drugs Exp Clin Res; 1991; 17(1):3-7. PubMed ID: 1914834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The thermographic assessment of inflammation and anti-inflammatory drugs in osteoarthritis.
    Ring EF; Dieppe PA; Bacon PA
    Br J Clin Pract; 1981; 35(7-8):263-4. PubMed ID: 7032564
    [No Abstract]   [Full Text] [Related]  

  • 33. Osteoarthritis: a new look at an old disease.
    Moskowitz RW
    Geriatrics; 1973 Jun; 28(6):121-8. PubMed ID: 4267809
    [No Abstract]   [Full Text] [Related]  

  • 34. Symptomatic slow-acting drugs for osteoarthritis: what are the facts?
    Dougados M
    Joint Bone Spine; 2006 Dec; 73(6):606-9. PubMed ID: 17126058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Establish the optimal dosage of TSA-234 (rhSOD) in the treatment of osteoarthritis].
    Ryumachi; 1995 Jun; 35(3):621-35. PubMed ID: 7570219
    [No Abstract]   [Full Text] [Related]  

  • 36. Practical management of osteoarthritis. Integration of pharmacologic and nonpharmacologic measures.
    Griffin MR; Brandt KD; Liang MH; Pincus T; Ray WA
    Arch Fam Med; 1995 Dec; 4(12):1049-55. PubMed ID: 7496554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Definitions and clinical experimentation of anti-osteoarthritis agents/chondro-protectors. Survey among private rheumatologists].
    Maheu E; Dropsy R
    Rev Rhum Mal Osteoartic; 1990 Oct; 57(9 ( Pt 2)):44S-50S. PubMed ID: 2080415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Assessment of the placebo effect of symptomatic slow-acting anti-arthritics].
    Villani P; Bouvenot G
    Presse Med; 1998 Feb; 27(5):211-4. PubMed ID: 9768015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pathobiology of osteoarthritis and the rationale for using the chondroitin sulfate for its treatment.
    Volpi N
    Curr Drug Targets Immune Endocr Metabol Disord; 2004 Jun; 4(2):119-27. PubMed ID: 15180452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative treatments for your arthritis pain. Tai chi, fish oil, and capsaicin gel might be effective, drug-free alternatives to NSAIDs.
    Duke Med Health News; 2009 Sep; 15(9):4-5. PubMed ID: 19785079
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.